RenovoRx and TIGeR-PaC Leadership to Host RenovoTAMP™ Webinar on June 21, 2022Business Wire • 06/09/22
RenovoRx to Participate in the University of Cambridge's Academy of Therapeutic Sciences Gateway to Translation Seminar Series on June 8, 2022Business Wire • 06/02/22
RenovoRx to Present Preclinical Research Data Demonstrating its Innovative Therapy Platform's Potential Utility for the Treatment of Bile Duct CancerBusiness Wire • 05/19/22
RenovoRx to Participate in Upcoming H.C Wainwright Global Investment Conference in May 2022Business Wire • 05/18/22
RenovoRx Sponsors Pancreatic Cancer Action Network's PurpleStride Event to End Pancreatic CancerBusiness Wire • 04/19/22
RenovoRx Enrolls First Pancreatic Cancer Patient at Columbia University's New York-Presbyterian Hospital Irving Medical Center in Ongoing TIGeR-PaC Phase 3 Clinical TrialBusiness Wire • 02/22/22
RenovoRx to Host “Delivering Therapy Where it Matters” Fireside Chat with CEO, Shaun Bagai, on February 23rd at 12 P.M. ETBusiness Wire • 02/03/22
RenovoRx Announces Presentation at the 2022 SPECTRUM Conference Highlighting Its Innovative RenovoTAMP™ Therapy for Targeted Treatment of CancerBusiness Wire • 01/19/22
5 Short Squeeze Candidates To Watch: Pioneer Power, NuZee Remain At The Top, Grab Rejoins The LeaderboardBenzinga • 12/06/21
5 Short Squeeze Candidates To Watch: Pioneer Power Tops List Along With Newegg, Nuzee And MoreBenzinga • 11/29/21
RenovoRx Announces Presentation of Final Data from RR2 Observational Registry Study at 2021 Pancreas Club Annual MeetingBusiness Wire • 11/11/21
Presentation During New Advances in the Management of Pancreatic Cancer Course Highlights Intra-Arterial Chemotherapy as a Potential Innovative Treatment for Pancreatic CancerBusiness Wire • 11/09/21
RNXT Stock: The FDA News That Has Biotech Company RenovoRx Rocketing Higher TodayInvestorPlace • 09/07/21
RenovoRx Receives New 510(k) Clearance for its RenovoCath® Delivery System Designed for Targeted Treatment of Solid TumorsPRNewsWire • 09/07/21